Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance

被引:27
|
作者
Pu, Wenchen [1 ]
Zheng, Yuanyuan [1 ]
Peng, Yong [1 ]
机构
[1] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, West China Hosp, Lab Mol Oncol,State Key Lab Biotherapy & Canc Ctr, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Pin1; PPIase isomerase; phosphorylation; cis-trans isomerization; cancer hallmarks; NF-KAPPA-B; CIS-TRANS ISOMERIZATION; TUMOR-SUPPRESSOR; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROMYELOCYTIC LEUKEMIA; NUCLEAR TRANSLOCATION; MICRORNA BIOGENESIS; PROSTATE-CANCER; RETINOIC ACID;
D O I
10.3389/fcell.2020.00168
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is an evolutionally conserved and unique enzyme that specifically catalyzes the cis-trans isomerization of phosphorylated serine/threonine-proline (pSer/Thr-Pro) motif and, subsequently, induces the conformational change of its substrates. Mounting evidence has demonstrated that Pin1 is widely overexpressed and/or overactivated in cancer, exerting a critical influence on tumor initiation and progression via regulation of the biological activity, protein degradation, or nucleus-cytoplasmic distribution of its substrates. Moreover, Pin1 participates in the cancer hallmarks through activating some oncogenes and growth enhancers, or inactivating some tumor suppressors and growth inhibitors, suggesting that Pin1 could be an attractive target for cancer therapy. In this review, we summarize the findings on the dysregulation, mechanisms, and biological functions of Pin1 in cancer cells, and also discuss the significance and potential applications of Pin1 dysregulation in human cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Prolyl Isomerase, Pin1, Controls Meiotic Progression in Mouse Oocytes
    Hoshino, Yumi
    Uchida, Takafumi
    CELLS, 2022, 11 (23)
  • [42] Dissecting the functional behavior of the differentially phosphorylated prolyl isomerase, Pin1
    Kay, Danielle F.
    Ozleyen, Adem
    De Las Heras, Cristina Matas
    Doveston, Richard G.
    Leney, Aneika C.
    PROTEIN SCIENCE, 2024, 33 (09)
  • [43] A critical step for JNK activation: isomerization by the prolyl isomerase Pin1
    Park, J. E.
    Lee, J. A.
    Park, S. G.
    Lee, D. H.
    Kim, S. J.
    Kim, H-J
    Uchida, C.
    Uchida, T.
    Park, B. C.
    Cho, S.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (01): : 153 - 161
  • [44] Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1
    Wang, Xingsheng
    Mahoney, Brendan J.
    Zhang, Meiling
    Zintsmaster, John S.
    Peng, Jeffrey W.
    STRUCTURE, 2015, 23 (12) : 2224 - 2233
  • [45] The prolyl isomerase PIN1 controls fibroblast state plasticity to impact pancreatic cancer.
    Langer, Ellen M.
    Shah, Vidhi
    Farrell, Amy
    Daniel, Colin
    Wang, Xiaoyan
    MacPherson, Kevin
    Allen-Petersen, Brittany L.
    Tsuda, Motoyuki
    Sherman, Mara
    Adey, Andrew
    Sears, Rosalie C.
    CANCER RESEARCH, 2022, 82 (22) : 149 - 150
  • [46] Prolyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration
    Angelucci, Francesco
    Hort, Jakub
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (01) : 59 - 62
  • [47] Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer
    Finn, Greg
    Lu, Kun Ping
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 223 - 229
  • [48] Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer
    Tsang, Y-H Nicole
    Wu, X-W
    Lim, J-S
    Ong, C. Wee
    Salto-Tellez, M.
    Ito, K.
    Ito, Y.
    Chen, L-F
    ONCOGENE, 2013, 32 (12) : 1488 - 1496
  • [49] Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer
    Y-H Nicole Tsang
    X-W Wu
    J-S Lim
    C Wee Ong
    M Salto-Tellez
    K Ito
    Y Ito
    L-F Chen
    Oncogene, 2013, 32 : 1488 - 1496
  • [50] The Roles of the Unique Prolyl Isomerase Pin1 in Cancer-Related Viral and Bacterial Infections
    Wang, J.
    Liao, X. -H.
    Zheng, M.
    Yang, D.
    Zhou, X. Z.
    Liu, H.
    Lu, K. P.
    CURRENT MOLECULAR MEDICINE, 2016, 16 (09) : 793 - 802